Co-trimoxazole
(combination of 80 mg of trimethoprim and 400 mgof sulfamethoxazole per g or per tablet) is widely used for treatment and prophylaxis of Pneumocystis carinii pneumonia (PCP), an opportunistic infection which frequently occurs in immunocompromised hosts (1) . Because of the low incidence of toxicity, co-trimoxazole has beenrecommended rather than pentamidineas the preferred drug for the treatment of PCP (2) . The fixed combination of pyrimethamine (25 mg) and sulfadoxine (500 mg) (pyrimethamine-sulfadoxine)
is also recommendedfor prophylaxis against PCP, as well as for treatment and prophylaxis of malaria (3). Although very rare, these agents are knownto cause severe, sometimes fatal, skin reactions including Stevens-Johnson syndrome (erythema multiforme major) (4, 5) and LyelFs syndrome or toxic epidermal necrolysis (TEN) (4, 6, 7). The incidence of pyrimethamine-sulfadoxine related
TENamongAmerican travelers was estimated to be one per 5,000-8,000 users (4) . These studies have been conducted on persons without acquired immunodeficiency syndrome (AIDS).
PCP is the most frequent opportunistic infection in patients with AIDS(8). As the number of patients with AIDS is rapidly growing every year, the frequency of co-trimoxazole and pyrimethaminesulfadoxine being prescribed is likely also increasing. AmongHIV-infected patients, one fetal case of TEN associated with pyrimethamine-sulfadoxine prophylaxis for PCP has been reported to date (9, 10). Although it is reported that the incidence of various skin reactions to co-trimoxazole amongpatients with AIDS is considerably higher than that among patients without AIDS (1 1), the incidence of TEN among patients with AIDS has not yet been reported. Here, we describe TEN observed in 3 of 4 patients with AIDS who had been treated with cotrimoxazole or pyrimethamine-sulfadoxine. Based to HIV-infected patients, especially when treating those with AIDS.
CASE REPORTS
Case 1: In August 1986, a 26-year-old man was transferred to our hospital with high fever, erythema and dyspnea. A diagnosis of hemophilia A had been made at the age of 2, and blood products (coagulation factor 8) had been given once every 2-3 months. He lost 6 kg in the 6 months prior to admission. Two days before admission to another hospital, high fever and a dry cough developed, and he became dyspneic. Physical examination revealed moist rales in bilateral lungs, and several enlarged lymph nodes, about 1 cm in diameter, in both sides of the neck and inguinal regions. Chest X-ray films revealed bilateral diffuse opacity and fine reticular shadow in bilateral lung fields compatible with PCP. Oral administration of co-trimoxazole at a dose of 4 g/day was started. Twodays later, the dose was increased to 10 g/day and clinical improvement was attained to some extent. Nine days after the start of co-trimoxazole treatment, erythema-like skin eruption appeared at first on the face and rapidly spread con fluently over the entire skin with pain. The patient was soon transferred to our hospital. and several enlarged lymph nodes, about 1 cm in diameter, in both sides of the neck and right axilla. Bacterial pneumonia was first suspected based on the findings of chest X-ray films, and clindamycin was administered, which was discontinued four days later because it was not effective. Thus, pyrimethamine-sulfadoxine was the only drug which was continued regularly.
One week after admission, an induration of the skin with central necrosis was noticed on the right side of the chest wall. Several days later, erythema and blisters appeared on his anterior chest, and spread over the trunk in a few days. Pyrimethamine-sulfadoxine was discontinued after the sixth dose, however, increased in number and size, and subsequently ruptured. The dose of steroid was in- Although biopsy was not carried out in case 3, the clinical findings in case 3 were the most convincing amongthese three cases, and the diagnosis was confirmed by an experienced dermatologist. The syndrome recognized in babies and children is typically due to a circulating staphylococcal epidermolytic toxin, and is often referred to as staphylococcal scaled skin syndrome (14). In adults, however, adverse drug reactions are the principal cause of the syndrome; sulfonamides including cotrimoxazole and pyrimethamine-sulfadoxine are the most frequent drugs responsible (4, 6) . Details of pathogenesis of the syndrome in adults is not known, but it is generally assumed to be an immunologically mediated reaction in the skin (1 3 phenomenasuch as the appearance of antinuclear antibodies, antibodies against platelets , lymphocytes, granulocytes and phospholipids , circulating immune complexes, rheumatoid factor, positive Coombstest, and so on (21). These abnormalities in patients with AIDS may be somehow linked to the increased skin reactivity against co-trimoxazole (ll), and to the production of drug-dependent antiepidermal antibodies, which are occasionally found in patients with TEN (22) . Although these immunological abnormalities were not investigated in the present cases, the levels of IgG and IgA were elevated, suggesting the presence of abnormalities in humoral immunity. In our hospital, a total of 26 patients with AIDS have been treated. Co-trimoxazole was prescribed to one patient only (case 1) for the treatment of PCP, and pyrimethamine-sulfadoxine to three patients including cases 2 and 3 presented here. No other patients received sulfonamide-containing drugs. Thus, three of four patients with AIDSwho received sulfonamide-containing drugs exclusively developed TEN as described above. After we recognized the third case, we stopped using sulfonamide-containing drugs, and pentamidine treatment was chosen instead. Subsequently 14 patients with PCP have been treated with pentamidine, and none of them developed TEN. The other drugs administered to the present three cases have not been reported to cause TEN. Therefore, together with the previous observation that sulfonamides are most frequently responsible for TEN (4, 6, 7) , it may be feasible to assume that cotrimoxazole and pyrimethamine-sulfadoxine are responsible in these cases also.
Because of severe cutaneous reactions, seven American travelers died of TEN and StevensJohnson syndrome, thus the routine weekly use of pyrimethamine-sulfadoxine for the prophylaxis of malaria have been warned (4) . As for AIDS, four surviving cases of Stevens-Johnson syndrome and one fatal case of TEN associated with pyrimethamine-sulfadoxine was reported by CDC (9, 23) . When an adverse reaction occurs, sulfadoxine has the disadvantage of a longer half-life than sulfamethoxazole. Although no such severe reaction has been reported since then, based on our experience it is important to warn that TENmay occur rather frequently amongpatients with AIDS whensulfonamides are used. This is supported by a retrospective observation by Gordon et al (ll) in which only five of 37 patients with AIDS who started with co-trimoxazole treatment were able to complete the treatment. In 29 patients drug toxicity occurred, and in 19 the treatment was changed due to adverse reactions that included rash, fever, and neutropenia; pentamidine was less toxic, and more tolerable (1 1).
TEN is very severe and can be fatal in itself.
Moreover, because most of the skin is peeled off 
